Strategic Application of PBPK Modeling for Predicting DDIs & the Effects of Smoking & Organ Impairment
Olanzapine is a highly effective antipsychotic, but its uses are limited by the risk of…
CertaraDecember 23, 2021
ScienceDirect: Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: The TOGETHER randomized platform clinical trial
Observational studies have postulated a therapeutic role of metformin in treating COVID-19. We conducted ...(cont.)
CertaraDecember 22, 2021
Certara Announces FDA Renewal and Expansion of Certara’s Biosimulation Software for Reviewing Regulatory Submissions
FDA holds more than 400 SimcypTM and PhoenixTM software licenses across 12 divisions and offices…
CertaraDecember 21, 2021
P21 Releases New PMDA Validation Engine
New PMDA Engine Pinnacle 21 is happy to announce the latest Validation Engine for submissions…
CertaraDecember 20, 2021
A Bird’s Eye View on Rare Diseases: Key Drug Development Considerations for Thyroid Eye Disease
New therapeutics discovery and development for ocular diseases have been traditionally associated with a low…
CertaraDecember 15, 2021
Certara Announces Release of Pinnacle 21 Enterprise Software
New metrics and analytics capabilities enable informed decision making for biopharmaceutical clients PRINCETON, N.J., Dec.…
CertaraDecember 13, 2021
Predicting and Taming Immunogenicity: Strategies for your Biologic Drug
Immunogenicity is the ability of a foreign substance, such as a drug or vaccine, to…
CertaraNovember 19, 2021
Accelerating the establishment of precision medicine using PK-PD/TD modeling
Certara’s Japan team first met Dr. Kobuchi when he was studying Pharmacometrics at university for…
CertaraNovember 18, 2021
